Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US
Event date: 9th June 2021
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June.
In this webinar we will explore considerations for implementing an effective strategy to secure patent protection for personalised medical devices, and to steer through a potentially crowded competitive landscape, with a particular focus on comparing the European and US jurisdictions.
The emergence of new platform technologies directed to patient-specific healthcare solutions has led to significant investment and R&D associated with personalised medical devices. In order to protect their technological innovations, many companies are striving to strategically develop global patent portfolios that support the commercialisation of their products and which can leverage a dominant commercial position over competitors. As national and regional differences exist between legal provisions that govern intellectual property, it is not always possible to adopt a “one-size-fits-all” approach. A more thorough understanding of these differences is therefore vital when seeking to maximise the scope of protection available to the patent proprietor or to minimise patent infringement risk when commercialising personalised medical devices.
This webinar will cover:
- an overview of the growth in patent applications for personalised medical devices and examples of patent claims that can protect them;
- considerations for drafting and prosecuting patent applications directed to personalised medical devices and how these approaches differ between Europe and the US;
- a case study examining litigation, in the US, of a patent portfolio with claims covering personalised medical devices and how defendants challenged patent validity.
Dr Adam Hines, HGF
Christy Lea, Knobbe Martens
Sabing Lee, Knobbe Martens
4.00 pm (BST)
8.00 am (PT)
10.00 am (CT)
11.00 am (ET)